A novel approach to achieving modular retrovirus clearance for a parvovirus filter

Biotechnology Progress

Volumn 30, Issue 1, 2014, Pages 79-85

  Stuckey, Juliana ^a   Strauss, Daniel ^a   Venkiteshwaran, Adith ^a   Gao, Jinxin ^a   Luo, Wen ^a   Quertinmont, Michelle ^a   O'Donnell, Sean ^a   Chen, Dayue ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Modular clearance; Regulatory compliance; Viral clearance; Viral safety

Indexed keywords

DOWNSTREAM PURIFICATIONS; INDUSTRY STANDARDS; MAMMALIAN CELL CULTURE; MODULAR CLEARANCE; MURINE LEUKEMIA VIRUS; SIZE EXCLUSION MECHANISM; VALIDATION STUDY; VIRAL CLEARANCE;

CELL CULTURE; ONCOGENIC VIRUSES; REGULATORY COMPLIANCE;

ACCIDENT PREVENTION;

MAMMALIA; MURINE LEUKEMIA VIRUS; PARVOVIRUS; PORCINE PARVOVIRUS; XENOTROPIC MURINE LEUKEMIA VIRUS;

ARTICLE; CULTURE TECHNIQUE; EQUIPMENT; EQUIPMENT DESIGN; FILTRATION; ISOLATION AND PURIFICATION; METHODOLOGY; MODULAR CLEARANCE; PARVOVIRUS; REGULATORY COMPLIANCE; RETROVIRUS; STANDARD; VIRAL CLEARANCE; VIRAL SAFETY;

MODULAR CLEARANCE; REGULATORY COMPLIANCE; VIRAL CLEARANCE; VIRAL SAFETY;

CELL CULTURE TECHNIQUES; EQUIPMENT DESIGN; FILTRATION; PARVOVIRUS; RETROVIRIDAE;

EID: 84893763018     PISSN: 87567938     EISSN: 15206033     Source Type: Journal    
DOI: 10.1002/btpr.1820     Document Type: Article

References (19)

1. Guideline on virus safety evaluation of biotechnological investigational medicinal products. London, UK: European Medicines Agency. 2008; Doc. Ref. EMEA/CHMP/BWP/398498/2005.
2. Points to consider in the manufacture and testing of monoclonal antibody products for human use. Rockville, Maryland: Food and Drug Administration. 1997.
3. Guidance on Viral Safety Evaluation of Biotechnology Products Derived From Cell Lines of Human or Animal Origin, Q5A. Geneva, Switzerland: International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. 1998.
4. Garnick RL. Experience with viral contamination in cell culture, Dev Biol Stand. 2006;88:49-56.
5. Skrine J. A biotech production facility contamination case study-minute mouse virus, PDA J Pharm Sci Technol. 2011;65:599-611.
6. Moody M, Alves W, Varghese J, Khan F. Mouse minute virus (MMV) contamination-A case study: Detection, root cause determination, and corrective actions, PDA J Pharm Sci Technol. 2011;65:580-588.
7. Miesegaes G, Bailey M, Willkommen H, Chen Q, Roush D, Blümel J, Brorson K. Proceedings of the 2009 Viral Clearance symposium, Dev Biol. 2010;133:77-91.
8. Hongo-Hirasaki T, Komuro M, Ide S. Effect of antibody solution conditions on filter performance for virus removal filter Planova 20N, Biotechnol Prog. 2010;26:1080-1087.
9. Asher D, Slocum A, Bergmann K, Genest P, Katz A, Morais J, Lawrence C, Greenhalgh P. Predicting virus filtration performance with virus spike characterization, Bioprocess Int. 2011;9:26-37.
10. Hongo-Hirasaki T, Yamaguchi K, Yanagida K, Hayashida H, Ide S. Effects of varying virus-spiking conditions on a virus-removal filter Planova™ 20N in a virus validation study of antibody solutions, Biotechnol Prog. 2011;27:162-169.
11. Lutz H, Chang W, Blandl T, Ramsey G, Parella J, Fisher J, Gefroh E. Qualification of a novel inline spiking method for virus filter validation, Biotechnol Prog. 2011;27:121-128.
12. Bolton G, Basha J, Lacasse D. Achieving high mass-throughput of therapeutic proteins through parvovirus retentive filters, Biotechnol Prog. 2011;26:1671-1677.
13. Slocum A, Burnham M, Genest P, Venkiteshwaran A, Chen D, Hughes J. Impact of virus preparation quality on parvovirus filter performance, Biotechnol Bioeng. 2013;110:229-239.
14. Bolton G, Cabatingan M, Rubino M, Lute S, Brorson K, Bailey M. Normal-flow virus filtration: Detection and assessment of the endpoint in bio-processing, Biotechnol Appl Biochem. 2005;42:133-142.
15. Lute S, Bailey M, Combs J, Sukumar M, Brorson K. Phage passage after extended processing in small-virus-retentive filters, Biotechnol Appl Biochem. 2007;47:141-151.
16. Miesegaes G, Lute S, Brorson K. Analysis of viral clearance unit operations for monoclonal antibodies, Biotechnol Bioeng. 2010;106:238-246.
17. Zhao X, Bailey MR, Emery WR, Lambooy PK, Chen D. Evaluation of viral removal by nanofiltration using real-time quantitative polymerase chain reaction, Biotechnol Appl Biochem. 2007;47:97-104.
18. Willcommen H, Blümel J, Brorson K, Chen D, Chen Q, Gröner A, Kreil T, Robertson J, Ruffing M, Ruiz S. Meeting Report-Workshop on virus removal by filtration: Trends and new developments, PDA J Pharm Sci Technol. 2013;67:98-104.
19. Lute S, Bailey M, Combs J, Sukumar M, Brorson K. Phage passage after extended processing in mall-virus retentive filters, Biotechnol Appl Biochem 2007;47:141-151.